About ASSO International Consulting
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.
Global Artificial Pancreas Devices Systems Strategic Report
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Summary
More businesses in the market research, data and insights industry are working toward a step change in their speed, efficiency and product innovation. This has led to a wider demand for more sophisticated and integrated solutions to meet the complex needs of larger established businesses and also newer, hyper-growth and technology-driven companies. ASSO's research report helps decision makers gain insight into market conditions and future trends.
To analyze and research the Artificial Pancreas Devices Systems sales, revenue, consumption, status and forecast.
To focus on the key Artificial Pancreas Devices Systems manufacturers and study the sales, value, market share and development plans in next few years.
To define, describe and forecast the market by type, application.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Global Artificial Pancreas Devices Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The major players in global market include
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
...
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Artificial Pancreas Devices Systems in these regions, from 2013 to 2024 (forecast), covering
North America (United States,Canada, Mexico)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
South America (Brazil. Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
On the basis of product, the Artificial Pancreas Devices Systems market is primarily split into
Threshold?Suspended?Device?Systems
Hybrid?Closed-loop?APDS
Other?Systems
On the basis on the end users/applications, this report covers
Hospitals
Clinics
Table of Contents
1 Target Product and Background
1.1 Product Overview @@@@
1.2 Research Method
1.3 Data Source
1.4 Project Cycle
1.5 Forecast Data Base & Factor
1.6 Macroeconomic Development Trends
1.7 Impact of COVID-19 on the Economy and Artificial Pancreas Devices Systems Industry
1.7.1 Post-COVID-19 era
1.7.2 The Impact of COVID-19 on Artificial Pancreas Devices Systems Industry
2 Manufacturers Competitive Analysis of Major Players
2.1 Competitive Segmentation Analysis of Key Players
2.2 2016-2021 Key Players Sales Volume and Market Positions
2.3 Key Players Revenue and Market Positions
3 Artificial Pancreas Devices Systems Sales Segment Analysis by Type
3.1 Overview
3.1.1 Threshold?Suspended?Device?Systems
3.1.2 Hybrid?Closed-loop?APDS
3.1.3 Other?Systems
3.2 2016-2027 Global Artificial Pancreas Devices Systems Sales Volume Segment Analysis by Type
3.3 2016-2027 Global Artificial Pancreas Devices Systems Revenue Segment Analysis by Type
4 Artificial Pancreas Devices Systems Sales Segment Analysis End User
4.1 Introduction
4.1.1 Hospitals
4.1.2 Clinics
4.2 2016-2027 Global Artificial Pancreas Devices Systems Sales Volume Segment Analysis by End User
4.3 2016-2027 Global Artificial Pancreas Devices Systems Revenue Segment Analysis by End User
5 Artificial Pancreas Devices Systems Market Analysis, by Region by Country
5.1 Global Artificial Pancreas Devices Systems Market Size and Regional Analysis
5.2 Global Artificial Pancreas Devices Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
5.3 North America Market Size and Regional Analysis
5.3.1 North America Sales by Country
5.3.2 North America Artificial Pancreas Devices Systems Revenue by Country
5.4 Europe Market Size and Regional Analysis
5.4.1 Europe Artificial Pancreas Devices Systems Sales by Country
5.4.2 Europe Artificial Pancreas Devices Systems Revenue by Country
5.5 Asia Pacific Market Size and Regional Analysis
5.5.1 Asia Pacific Artificial Pancreas Devices Systems Sales by Region
5.5.2 Asia Pacific Artificial Pancreas Devices Systems Revenue by Region
5.6 South America Market Size and Regional Analysis
5.6.1 South America Artificial Pancreas Devices Systems Sales by Country
5.6.2 South America Artificial Pancreas Devices Systems Revenue by Country
5.7 Middle East and Africa Market Size and Regional Analysis
5.7.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country
5.7.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country
6 Artificial Pancreas Devices Systems SWOT and Driving Factor Analysis
6.1 SWOT Analysis
6.2 Marketing Strategy
6.3 Technology Driven Market
6.4 Artificial Pancreas Devices Systems Growth Drivers
6.5 Artificial Pancreas Devices Systems Market Challenges
6.6 Artificial Pancreas Devices Systems Market Restraints
7 Artificial Pancreas Devices Systems Raw Material Supply and Industry Chain Analysis
7.1 Artificial Pancreas Devices Systems Key Raw Material Supply
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Artificial Pancreas Devices Systems Industrial Chain Analysis and Reconstruction
8 Global Artificial Pancreas Devices Systems Major Manufacturers Analysis
8.1 Medtronic
8.1.1 Medtronic Corporate Outline
8.1.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.1.3 Medtronic Artificial Pancreas Devices Systems Key Product Overview
8.1.4 Artificial Pancreas Devices Systems Key Product Overview
8.1.5 Medtronic Business Segmentation SWOT Analysis
8.2 Bigfoot Biomedical
8.2.1 Bigfoot Biomedical Corporate Outline
8.2.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Key Product Overview
8.2.4 Artificial Pancreas Devices Systems Key Product Overview
8.2.15Bigfoot Biomedical Business Segmentation SWOT Analysis
8.3 Beta Bionics
8.3.1 Beta Bionics Corporate Outline
8.3.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.3.3 Artificial Pancreas Devices Systems Key Product Overview
8.3.4 Artificial Pancreas Devices Systems Key Product Overview
8.3.5 Beta Bionics Business Segmentation SWOT Analysis
8.4 Admetsys
8.4.1 Admetsys Corporate Outline
8.4.1 Admetsys Corporate Outline
8.4.3 Artificial Pancreas Devices Systems Key Product Overview
8.4.4 Artificial Pancreas Devices Systems Key Product Overview
8.4.5 Admetsys Business Segmentation SWOT Analysis
8.5 Insulet
8.5.1 Insulet Corporate Outline
8.5.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.5.3 Artificial Pancreas Devices Systems Key Product Overview
8.5.4 Artificial Pancreas Devices Systems Key Product Overview
8.5.5 Insulet Business Segmentation SWOT Analysis
8.6 Tandem Diabetes Care
8.6.1 Tandem Diabetes Care Corporate Outline
8.6.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.6.3 Artificial Pancreas Devices Systems Key Product Overview
8.6.4 Artificial Pancreas Devices Systems Key Product Overview
8.6.5 Tandem Diabetes Care Business Segmentation SWOT Analysis
8.7 Defymed
8.7.1 Defymed Corporate Outline
8.7.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
8.7.3 Artificial Pancreas Devices Systems Key Product Overview
8.7.4 Artificial Pancreas Devices Systems Key Product Overview
8.7.5 Defymed Business Segmentation SWOT Analysis
9 Artificial Pancreas Devices Systems Report Conclusion and Strategy
10 Appendix
10.1 Order and After-sales Service
10.2 Author List
10.3 Disclaimer
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning
– Allen King
Leave a comment
All fields marked with an asterisk (*) are required